Submit the academic result
The researcher provides a concise non-confidential description of the discovery, existing evidence, unmet need and validation gap.
SoftMining Academic Foundry
A selective pathway for academic drug-discovery projects that need funding, international collaboration and decisive preclinical validation.
The win–win structure
The initial assessment and grant preparation start at no cost. An 8% fee applies only to funding obtained; the calculation basis, debtor and payment terms are agreed in writing.
For post-validation development, SoftMining’s share in the new asset is negotiated case by case according to its role and never exceeds 50%, subject to the project agreement.
The academic validation gap
A result may be publishable and scientifically important without yet being investable, licensable or ready for pharmaceutical development.
The Foundry pathway
Projects start non-confidentially. Only scientifically strong and fundable opportunities proceed to deeper review, consortium construction and funded validation.
The researcher provides a concise non-confidential description of the discovery, existing evidence, unmet need and validation gap.
ADAPT evaluates robustness, translational potential, validation needs, development feasibility and grant readiness.
If the project passes the threshold, SoftMining identifies the most suitable call, assembles the international consortium and prepares the application.
The funded programme performs the decisive biological, mechanistic, DMPK, safety, formulation or preclinical studies agreed for the project.
When predefined validation criteria are met, the academic contribution and SoftMining’s development contribution are recognised in the exploitation model.
Foundry infrastructure
These tools belong to the Academic Foundry pathway and are used together only after the scientific project passes the initial threshold.
Evaluates scientific quality, translational maturity, validation requirements and fundability.
Explore the technical ADAPT architecture →Identifies complementary international partners and builds the consortium.
Matches the scientific project with the most suitable competitive funding opportunities.
Structures and prepares the submission using project, call and consortium data.
Transparent economics
Academic teams can begin without an upfront fee. SoftMining is compensated only when funding is secured; any share in a new asset is negotiated after validation.
When the grant is funded
The fee applies only to funding obtained. Its calculation basis, debtor and payment terms are agreed in writing. The fee is not automatically eligible as a grant cost.
After successful validation
Based on SoftMining’s role, any share in the new asset is negotiated case by case and never exceeds 50%. Ownership, exploitation and licensing terms remain subject to predefined scientific criteria and signed institutional agreements.
Clear rules from the beginning
Submission is not an assignment. Rights, milestones and responsibilities become operative only through the relevant institutional and project agreements.
Initial submission and ADAPT assessment do not, by themselves, transfer rights to SoftMining.
Projects begin with non-confidential information and move to NDA-protected review when appropriate.
Scientific milestones, contributions, budgets and decision gates are agreed before funded work begins.
Background IP, publication, licensing and rights in validated Project Molecules are defined contractually.
What the Foundry selects
Selection is intentionally selective. SoftMining advances projects where its platform, funding intelligence and development capability can materially change the trajectory.
Start non-confidentially
Send a concise description of the scientific result, supporting evidence, unmet need and the experiment that would most change the project’s value.
target · molecule · mechanism
experiments · publications · data
validation · funding · partners